… This paper provides an overview on the biology, monitoring and management of differentiated
thyroid cancer (DTC), with particular attention to issues of relevance to clinical chemistry. …

… of thyroid cancer. This paper will not discuss off-label use of combination TKI therapy …
not been well established in thyroid cancer patients and are beyond the scope of this paper. …

… , and molecular-targeted therapies with tyrosine kinase inhibitors. This article … of thyroid
cancer, with recommendations from the American Thyroid Association regarding thyroid nodules …

… Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer.
… Brain metastases were most commonly detected during the monitoring of the patient after …

… In the Consensus discussion, it is noted that the early detection of a tumor recurrence may
affect thyroid cancer mortality (4), but the reference cited examines the delay in initial treatment…

… Considerable changes have occurred in the management of differentiated thyroid cancer
(… in therapy, including surgery, the use of radioactive iodine (radioiodine), thyroid hormone …

… We analysed data from routine HRQOL monitoring at a nuclear medicine department.
Between 2005 and 2013, a total of 439 thyroid cancer patients (all histologies) completed the …

… Targeted treatments that are approved for differentiated and medullary thyroid cancers
have prolonged progression-free survival, but these drugs are not curative and therefore are …

… Surgery for advanced thyroid cancer or repeated thyroid surgery … than surgery for limited
thyroid cancer. The extent of surgery … thyroid surgeries and early postoperative monitoring. …